Company Filing History:
Years Active: 2003
Title: Erkki Koivunen: Innovator in Matrix Metalloproteinase Inhibitors
Introduction
Erkki Koivunen is a notable inventor based in Hyvinkää, Finland. He has made significant contributions to the field of biochemistry, particularly in the development of matrix metalloproteinase inhibitors. His work has implications for pharmaceutical applications and research.
Latest Patents
Erkki Koivunen holds a patent for "Matrix metalloproteinase inhibitors and down-regulators." This invention relates to novel matrix metalloproteinase (MMP) inhibitors and down-regulators. It includes a process for preparing these inhibitors, pharmaceutical compositions containing them, and methods for inhibiting MMP-dependent conditions both in vivo and in vitro. The patent also covers the use of these inhibitors in biochemical isolation and purification procedures of matrix metalloproteinases.
Career Highlights
Erkki Koivunen is associated with Ctt Cancer Targeting Technologies Oy, where he applies his expertise in matrix metalloproteinases. His innovative work has the potential to advance cancer treatment and improve therapeutic strategies.
Collaborations
He has collaborated with notable colleagues such as Timo Arto Sorsa and Tuula A Salo, contributing to the advancement of research in his field.
Conclusion
Erkki Koivunen's contributions to the development of matrix metalloproteinase inhibitors highlight his role as an influential inventor in biochemistry. His work continues to impact pharmaceutical research and development.